Rislenemdaz

A potent, orally bioavailable brain‐penetrant, NR2B-selective NMDA receptor (GluN2B) antagonist with Ki and IC 50 of 8.1 nM and 3.6 nM respectively.

808732-98-1

≥ 2 years

>98% (HPLC)

358.417

C19H23FN4O2

Research use only, not for human use.

IGluR

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

BZ52788 1 Vial

Ask

MBS1029053-01 0.02 mg (E-Coli)

Ask

MBS1029053-02 0.02 mg (Yeast)

Ask

MBS1029053-03 0.1 mg (E-Coli)

Ask

MBS1029053-04 0.1 mg (Yeast)

Ask

MBS1029053-05 0.02 mg (Baculovirus)

Ask